ATE473448T1 - Verfahren zur diagnose von herz-kreislauf- krankheiten - Google Patents

Verfahren zur diagnose von herz-kreislauf- krankheiten

Info

Publication number
ATE473448T1
ATE473448T1 AT07718389T AT07718389T ATE473448T1 AT E473448 T1 ATE473448 T1 AT E473448T1 AT 07718389 T AT07718389 T AT 07718389T AT 07718389 T AT07718389 T AT 07718389T AT E473448 T1 ATE473448 T1 AT E473448T1
Authority
AT
Austria
Prior art keywords
amount
precursor
fragments
sample
cardiovascular diseases
Prior art date
Application number
AT07718389T
Other languages
English (en)
Inventor
Hendrik Ankersmit
Original Assignee
Univ Wien Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Wien Med filed Critical Univ Wien Med
Application granted granted Critical
Publication of ATE473448T1 publication Critical patent/ATE473448T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G01N33/6869—Interleukin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4742—Keratin; Cytokeratin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G01N2333/54—Interleukins [IL]
    • G01N2333/545—IL-1
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G01N2800/324—Coronary artery diseases, e.g. angina pectoris, myocardial infarction

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Braking Systems And Boosters (AREA)
AT07718389T 2006-04-24 2007-04-16 Verfahren zur diagnose von herz-kreislauf- krankheiten ATE473448T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT6942006 2006-04-24
PCT/AT2007/000173 WO2007121495A2 (en) 2006-04-24 2007-04-16 Method for diagnosing cardiovascular diseases

Publications (1)

Publication Number Publication Date
ATE473448T1 true ATE473448T1 (de) 2010-07-15

Family

ID=38171226

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07718389T ATE473448T1 (de) 2006-04-24 2007-04-16 Verfahren zur diagnose von herz-kreislauf- krankheiten

Country Status (7)

Country Link
US (1) US8129135B2 (de)
EP (1) EP2010921B1 (de)
JP (1) JP2009534672A (de)
AT (1) ATE473448T1 (de)
DE (1) DE602007007595D1 (de)
ES (1) ES2346483T3 (de)
WO (1) WO2007121495A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2937339B1 (fr) * 2008-10-21 2013-02-15 Univ Bourgogne Procede de detection de la maladie atheromateuse.
GB0911569D0 (en) 2009-07-03 2009-08-12 Ulive Entpr Ltd Method for the detection of organ or tissue injury
CN104483488A (zh) * 2009-08-28 2015-04-01 阿斯图特医药公司 肾损伤和肾衰竭的诊断及预后的方法及组合物
CN110089999A (zh) * 2018-01-31 2019-08-06 上海交通大学 基于角蛋白片段和角蛋白水平及左右对称性的检测判断心脑血管疾病的应用和方法
CN110089997A (zh) * 2018-01-31 2019-08-06 上海交通大学 基于体表自发荧光左右对称性和强度判断心肌梗死和心力衰竭及愈后程度的方法及其应用
CN110090001A (zh) * 2018-01-31 2019-08-06 上海交通大学 自发荧光在判断心脑血管病中的应用
CN110095440A (zh) * 2018-01-31 2019-08-06 上海交通大学 基于体表自发荧光左右对称性和强度判断脑卒中发生及愈后程度的方法及其应用
CN110132906A (zh) * 2018-02-02 2019-08-16 上海交通大学 基于指甲自发荧光左右对称性和强度判断心肌梗死和心力衰竭及愈后程度的方法及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2321351T3 (es) * 1997-09-30 2009-06-04 Peviva Ab Compuesto relacionados con apoptosis y su uso.
EP1666881B1 (de) * 2001-05-04 2010-02-17 Biosite Incorporated Diagnostische Marker der akuten koronaren Syndrome und ihre Verwendungen
PL2084543T3 (pl) * 2006-10-26 2018-04-30 B.R.A.H.M.S Gmbh Stratyfikacja ryzyka ostrego zespołu wieńcowego za pomocą fragmentów/ częściowych peptydów prowazopresyny, a zwłaszcza kopeptyny lub neurofizyny II

Also Published As

Publication number Publication date
ES2346483T3 (es) 2010-10-15
JP2009534672A (ja) 2009-09-24
WO2007121495A2 (en) 2007-11-01
WO2007121495A3 (en) 2008-02-21
US20090098104A1 (en) 2009-04-16
DE602007007595D1 (en) 2010-08-19
US8129135B2 (en) 2012-03-06
EP2010921A2 (de) 2009-01-07
EP2010921B1 (de) 2010-07-07

Similar Documents

Publication Publication Date Title
ATE473448T1 (de) Verfahren zur diagnose von herz-kreislauf- krankheiten
WO2005048823A3 (en) Modeling of systemic inflammatory response to infection
ATE514950T1 (de) Verfahren zur untersuchung von sepsis bei menschen
MX2009000914A (es) Medios y metodos para evaluar el riesgo de intervenciones cardiacas basadas en el factor 15 de diferenciacion del crecimiento.
WO2006036744A3 (en) Methods for a global assay of coagulation and fibrinolysis
ATE452343T1 (de) Verbesserte vitamin-d-messung
ATE482398T1 (de) Verfahren zur stratifizierung von herzinsuffizienz
ATE440151T1 (de) Verfahren zur beurteilung eines krankheitzustandes mittels nachweis von partikel- und nicht partikelgebundenen nukleinsäuren in blutplasma und -serum
ATE478335T1 (de) Verfahren in echtzeit zur erkennung von akuten entzündungszuständen
WO2007090126A3 (en) Compositions and methods for detecting and quantifying toxic substances in disease states
WO2005042761A3 (en) Biomarkers for amyotrophic lateral sclerosis
ATE514948T1 (de) In vitro verfahren zur diagnose von neurodegenerativen erkrankungen
EP1733234A4 (de) Verfahren zur bestimmung einer allergenreaktion unter verwendung von mikroarray-immunoassay-techniken
WO2006092729A3 (en) Novel biomarkers for diagnosis and/or prognosis or prognosis of neoplasias in animals
HRP20191862T1 (hr) Procjena rizika u liječenju antibioticima kod pacijenata koji boluju od primarne nezarazne bolesti određivanjem razine prokalcitonina
EP1977234A4 (de) Moleküle zur behandlung von lungenerkrankungen mit einer immunreaktion mit verbindungsgewebe in der lunge
ATE483982T1 (de) Liquordiagnostisches in vitro verfahren zur diagnose von demenz-erkrankungen und neuroinflammatorischen erkrankungen
DE60317070D1 (de) Verfahren zur diagnose von multipler sklerose
ATE437182T1 (de) Diagnose von allergischen erkrankungen, atopischen erkrankungen und/oder autoimmunerkrankungen durch nachweis von autoantikörpern gegen cd28 in humanem serum
ATE557277T1 (de) Verfahren zur diagnose von endometriose mittels tfpi-2 protein
WO2009016734A1 (ja) 軽度認知機能障害の検定方法
ATE355389T1 (de) Verfahren zur diagnose von schizophrenie
WO2007076447A3 (en) Method of diagnosing chronic diarrhea
DE602005023973D1 (de) Verfahren zur diagnose von chronischem stress und verwandten erkrankungen
WO2008021879A3 (en) Method of diagnosing celiac disease

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 2010921

Country of ref document: EP